NCT05837767 - A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 24, 2023

Primary Completion Date

July 24, 2026

Study Completion Date

July 24, 2026

Conditions

Invasive Ductal Breast CarcinomaInvasive Ductal Breast Carcinoma Stage IVLobular Breast CarcinomaLobular Breast Carcinoma Stage IVNon Small Cell Lung CancerNSCLCGastrointestinal CancerGastrointestinal Squamous Cell CancerGastrointestinal AdenocarcinomaPancreatic CancerBladder CancerRenal Cell CarcinomaMelanomaSarcomaMetastatic Solid Tumor

Interventions

RADIATION

Stereotactic body radiotherapy

The primary site requiring palliative radiotherapy will receive conventional SBRT dosing of SBRT (or an alternate standard-of-care schedule).

RADIATION

Lattice Radiation Therapy

A second metastatic site (GTV volume at least 100 cc) will receive elective palliation with a lattice RT pattern (LRT).

Trial Locations (7)

10065

RECRUITING

Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York

10604

RECRUITING

Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison

11553

RECRUITING

Memorial Sloan Kettering Nassau (Limited protocol activities), Rockville Centre

11725

RECRUITING

Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities), Commack

07920

RECRUITING

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge

07748

RECRUITING

Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown

07645

RECRUITING

Memorial Sloan Kettering Bergen (Limited protocol activities), Montvale